Skip to main content
. 2024 Sep 17;5(1):100394. doi: 10.1016/j.bpsgos.2024.100394

Table 1.

Demographic, Clinical, and Cognitive Variables

HCs, n = 48 NCVHs, n = 34 PSZ, n = 56 Statistics
Site, Maryland:Yale 32:16 21:13 44:12 χ22 = 3.32; p = .19
Gender, F:M:O 30:18:0 26:8:0 17:39:0 χ22 = 20.78; p < .001
Age, Years 37.21 ± 13.30 49.82 ± 10.49 34.43 ± 10.54 F2,135 = 19.83; p < .001
Race, A:AA:C:Other 3:9:30:6 5:2:27:0 4:20:28:4 χ26 = 18.01; p < .01
Education, Years 16.30 ± 2.20 15.35 ± 2.50 13.96 ± 1.88 F2,132 = 14.94; p < .001
Parental Education 15.16 ± 3.25 14.15 ± 2.78 14.55 ± 2.50 F2,129 = 1.31; p = .28
CPZ Dose Equivalent, mg/day 366.19 ± 285.58
BPRS Total 1.08 ± 0.11 1.76 ± 0.33 1.76 ± 0.40 F2,127 = 68.67; p < .001
 BPRS hallucinations 1.00 ± 0.00 4.47 ± 1.01 3.30 ± 1.89 F2,127 = 67.67; p < .001
 BPRS delusions 1.00 ± 0.00 4.47 ± 1.04 2.91 ± 1.60 F2,127 = 82.14; p < .001
 BPRS positive 1.01 ± 0.04 3.68 ± 0.59 2.64 ± 1.19 F2,127 = 98.97; p < .001
 BPRS negative 1.05 ± 0.24 1.14 ± 0.46 1.71 ± 0.54 F2,127 = 31.78; p < .001
 BPRS disorganized 1.02 ± 0.08 1.11 ± 0.24 1.30 ± 0.42 F2,127 = 11.25; p < .001
LSHS Total 8.25 ± 7.22 23.42 ± 8.54 23.29 ± 9.31 F2,128 = 46.29; p < .001
WTAR 115.3 ± 12.15 113.47 ± 9.34 104.76 ± 14.17 F2,131 = 10.22; p < .001
MCCB Processing Speed 55.98 ± 12.97 53.76 ± 8.30 42.20 ± 11.57 F2,130 = 20.57; p < .001
MCCB Working Memory 54.23 ± 8.49 50.00 ± 9.46 44.56 ± 11.95 F2,130 = 10.87; p < .001
MCCB Verbal Learning 48.98 ± 8.02 47.30 ± 8.17 41.85 ± 9.96 F2,130 = 8.54; p < .001

Values are presented as mean ± SD or n.

A, Asian; AA, African American; BPRS, Brief Psychiatric Rating Scale; C, Caucasian; CPZ, chlorpromazine; F, female; HCs, healthy comparison subjects; LSHS, Launay-Slade Hallucinations Scale; M, male; MCCB, MATRICS Consensus Cognitive Battery; NCVHs, nonclinical voice hearers; O, other; PSZ, people with schizophrenia; WTAR, Wechsler Test of Adult Reading.